To ask the Secretary of State for Health and Social Care, if he will make it his policy to make covid-19 antibody testing available to (a) immunocompromised and (b) clinically extremely vulnerable patients in order that they can assess their own levels of vaccine protection.
Antibody testing is available in limited circumstances which includes some of those classed as immunosuppressed and clinical extremely vulnerable. However, there are currently no plans to implement antibody testing post-vaccination in order to determine levels of antibodies other than testing that is already in place. There remains uncertainty as to whether the presence of antibodies means that an individual cannot transmit the virus to others. The Joint Committee on Vaccination and Immunisation will continue to review emerging scientific evidence on the use of vaccines in those with immunosuppression and those classed as clinically extremely vulnerable and will update its advice as necessary.